Headline figures are illustrative modelled data for demo use until live datasets are connected.
Citable data asset
GCC Aesthetic Demand Index, Q2 2026
The GCC Aesthetic Demand Index is Qallora Trends' quarterly market-intelligence asset for aesthetic clinics, summarising modelled treatment demand, competitor movement and campaign opportunity signals across Dubai, Abu Dhabi, Riyadh and Doha.
Methodology combines treatment search themes, public content patterns, competitor campaign observations and enquiry-intent clustering.
Dataset schema is included so search and AI systems can identify the page as a citable data asset.
Illustrative Q2 2026 headline signals
Dubai shows strong illustrative demand around HydraFacial and injectables education; Riyadh shows Arabic-first momentum around regenerative skin treatment explainers; Doha and Abu Dhabi show premium positioning opportunities around laser and skin boosters. These are labelled illustrative until real data feeds are connected.
Methodology
The production methodology should combine public search themes, social trend observations, competitor content samples, offer/category clustering, treatment-menu mapping and campaign-response learning. Qallora should publish source windows, exclusions and confidence notes each quarter.
Related intelligence
Use these internal pages to move from local market demand to treatment-specific campaign opportunities.
FAQ
What is the GCC Aesthetic Demand Index?
The GCC Aesthetic Demand Index is a quarterly Qallora Trends intelligence asset that summarises modelled treatment demand, competitor activity and campaign opportunity signals for aesthetic clinics across key GCC markets.
Are the Q2 2026 figures real market statistics?
The Q2 2026 figures on this demo page are illustrative modelled data, not verified market statistics; production versions should publish sourced methodology and clearly labelled data provenance.
Why does an index help AI-search visibility?
An index helps AI-search visibility because AI engines and journalists prefer citable, structured sources with a clear methodology, original framing and stable URLs.
All intelligence is for market and campaign planning. It is not clinical advice, legal advice, regulatory approval or financial advice. Final approval remains with the clinic and medical director.